ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 209,36
-0,37%
Dow Jones
39 908,00
0,88%
DAX
18 840,48
-0,18%
Brent Oil
82,805
0,18%
Bitcoin
66 182,41
-0,12%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Neurobiological Technologies (MM) (NTII)

  7. Neurobiological Technologies (MM) (NTII) Actualités

NTII

Neurobiological (NTII)

Neurobiological Technologies (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NTII
DateHeureSourceTitreSymboleSociété
07/12/200920h18Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
07/12/200919h41Edgar (US Regulatory)-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)NASDAQ:NTIINeurobiological Technologies (MM)
23/11/200914h00PR Newswire (US)Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per ShareNASDAQ:NTII
16/11/200919h43Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NTIINeurobiological Technologies (MM)
09/11/200922h30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
28/10/200914h00PR Newswire (US)Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and DissolutionNASDAQ:NTII
26/10/200919h00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTIINeurobiological Technologies (MM)
26/10/200918h59Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:NTIINeurobiological Technologies (MM)
23/10/200923h19Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:NTIINeurobiological Technologies (MM)
19/10/200922h20PR Newswire (US)Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital MarketNASDAQ:NTII
22/09/200912h01Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NTIINeurobiological Technologies (MM)
17/09/200923h00PR Newswire (US)Neurobiological Technologies Receives Nasdaq Closing Bid Price NotificationNASDAQ:NTII
08/09/200922h28Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NTIINeurobiological Technologies (MM)
31/08/200922h27PR Newswire (US)Neurobiological Technologies Announces Board Approval of Plan of Liquidation and DissolutionNASDAQ:NTIINeurobiological Technologies (MM)
31/08/200922h14Edgar (US Regulatory)Annual Report (10-K)NASDAQ:NTIINeurobiological Technologies (MM)
12/08/200914h30PR Newswire (US)Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Children's Medical CenNASDAQ:NTIINeurobiological Technologies (MM)
01/06/200914h30PR Newswire (US)Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical ProgramNASDAQ:NTIINeurobiological Technologies (MM)
08/05/200913h00PR Newswire (US)Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
01/05/200913h00PR Newswire (US)Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of MemantineNASDAQ:NTIINeurobiological Technologies (MM)
26/03/200912h30PR Newswire (US)Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of CompanyNASDAQ:NTIINeurobiological Technologies (MM)
18/02/200912h02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:NTIINeurobiological Technologies (MM)
12/02/200922h30PR Newswire (US)Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
05/02/200922h17Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:NTIINeurobiological Technologies (MM)
04/02/200913h00PR Newswire (US)Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEONASDAQ:NTIINeurobiological Technologies (MM)
23/01/200912h02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:NTIINeurobiological Technologies (MM)
13/01/200913h30PR Newswire (US)Neurobiological Technologies Announces Suspension of Viprinex DevelopmentNASDAQ:NTIINeurobiological Technologies (MM)
17/12/200813h00PR Newswire (US)Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility AnalysisNASDAQ:NTIINeurobiological Technologies (MM)
16/12/200814h00PR Newswire (US)Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009NASDAQ:NTIINeurobiological Technologies (MM)
06/11/200812h30PR Newswire (US)Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
05/11/200822h08Edgar (US Regulatory)Amended Securities Registration (section 12(g)) (8-A12G/A)NASDAQ:NTIINeurobiological Technologies (MM)
 Showing the most relevant articles for your search:NASDAQ:NTII

Dernières Valeurs Consultées

EU
PX4
SBF 120
EU
CAP
Capgemini
EU
BEL20
Bel 20
EU
ORA
Orange
EU
AF
Air FranceKLM
EU
BNP
BNP Paribas
NASDAQ
AAPL
Apple
EU
ACA
Credit Agricole
EU
LR
Legrand
EU
VK
Vallourec
NYSE
KO
Coca Cola
USI
USTECH100
US Tech 100
EU
DG
Vinci
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés